The Alfred E Mann Foundation for Scientific Research

What it reported doing in 2025

New project developmentthis program covers (a) the monitoring and evaluation of several early stage advanced research and development efforts underway that are directed at developing - innovative technologies, project ideas and concepts before they progress to the status of full-fledged development programs, and (b) ongoing efforts related to the advancement of commercial development and protection of intellectual property of these projects across the development lifecycle. The team comprises the full range of expertise available at amf/hmt, including executive management, research scientists and engineers, legal and intellectual property experts, business development strategists and analysts.expenses may include ongoing participation in the development effort, including research and development support, collaboration management, conference and professional society meeting attendance, service in management or on the board of directors of spinout entities, patent prosecution and the prosecution of infringement actions to protect the value of the intellectual property we create. In addition to payroll expenses and direct expenses paid to outside vendors for goods and services related to projects, expenses in this program may include travel expenses, patent prosecution expenses and fees, legal fees for expenses to create, preserve and protect intellectual property from infringement and remedy past infringement, and incentive and other compensation payments to employees and others related to these programs and actions. In some cases, certain of these expenditures might be incurred long after the programs have been launched into spinout companies or licensed to third parties.revenues associated with these projects (some of which may accrue long after the project and any related program have been outlicensed or launched into a spinout company) may include: recoveries of judgments or settlements from patent infringement and licensing matters, royalties on licensed product sales, milestone payments, ongoing contract r&d services provided to partners, licensees and spinout companies, interest, and proceeds from liquidity events (e.g., initial public offerings, acquisitions) involving retained equity interests in projects that have been spun out as startup companies.status: design and development activities are underway for a new bioelectronic program based on existing business case analyses. These activities include generation of initial system requirements, assembly of a team of key opinion leaders with domain expertise, and the initiation of some fundamental applied research in the area of novel stimulation techniques, including completion of pre-clinical testing. Additionally, the business development team, along with executive management and other staff, performed preliminary due diligence on a number of projects.

Financial Efficiency

• Mission deployment rate: 29.9%; rating input score 30
• Program expense ratio: 91.1%; rating input score 91
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 100%; rating input score 100; 66th percentile among comparable filings
• Pay-setting controls: 3 of 6 controls in place; rating input score 50
  • Compensation committee: Missing
  • Independent consultant: Pass
  • Other Form 990s reviewed: Missing
  • Written employment contract: Missing
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: Scored; rating input score 0
• Grant itemization coverage: 0%; rating input score 0; 3rd percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Limited

Accountability

• Independent voting board: 80%; rating input score 80; 14th percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 71.8%; rating input score 96; 96th percentile among comparable filings
• Total-asset coverage ratio: 7.81; rating input score 84; 84th percentile among comparable filings
• Liabilities to assets ratio: 0.02; rating input score 88; 88th percentile among comparable filings
• Officer compensation ratio: 8.6%; rating input score 6; 6th percentile among comparable filings

Growth

• Program expense growth: 11.8% per year; rating input score 100; 74th percentile among comparable filings
• Revenue growth: 18.6% per year; rating input score 100; 92nd percentile among comparable filings
• Asset growth: 12.1% per year; rating input score 100; 78th percentile among comparable filings